Québec companies at BIO Convention
Life Sciences industry trade mission to Boston, United-States during the BIO Convention 2023 trade fair.
June 5th to 8th, 2023
This trade mission is being organized by Investissement Québec International in conjunction with the Québec Government Office in Boston and the ministère de l'Économie, de l'Innovation et de l'Énergie.
Thanks to our select partners: Lavery, Médicaments novateurs Canada and Fonds FTQ.
List of companies
David Cotnoir-White
CEO
Mounia Azzi
Vice-president, Corporate Development
Patrick Bergeron, LL.B.
Director, Government Affairs
patrick.bergeron@astrazeneca.com
Guy Tropper
Executive Vice President
Rola Hamed
Client Relationship Manager
Katherine Jobin Gervais
Head, Market Access and Government Affairs
katherine.jobingervais@bauschhealth.com
Cédric Héroux
Business Development Director
Benoît Larose
CEO
Canadian Advanced Therapies Training Institute
Valerie Roussin-Paradis
Director, Business Development and Partnerships
Danika Laberge
President, CEO
Centre de recherche de l’Hôpital Douglas
Xavier Linker
Associate Director of Business Development
Yves Roy
President
CQDM - Consortium de recherche biopharmaceutique
Véronique Dugas
Vice President, Scientific Affairs
CQIB - Centre Québécois d’Innovation en Biotechnologie
Perry Niro
CEO
Suzie Talbot
President
Frédérik Plourde
Venture Associate
Luc Bessette
President and Founder
Francois-Thomas Michaud
CEO
Jamal Daoud
Executive Director
Josette-Renée Landry
President, CEO
Maxime Ranger
Executive Chairman
Isabelle Fortier
Canadian Director of Government Relations and Market Access
Idorsia Pharmaceuticals Canada
Sophie Rochon
Canadian Director of Government Relations and Market Access
Philip Roche
CEO
Peter Heessels
Vice President Business Development
Jean-Luc Berger
Business Development Manager
Janet Price
Senior Industry Liaison Officer
Yohan Tessier
VP Commercial Ops and Strategic Development
Stéphanie Doyle
Senior Director - Europe and SVTS
Vicky Azadian
Territory Manager
Lisa-Marie Lefebvre
Associate Director, Patient Access
Christian Dansereau
CEO
Paul Evans
VP Global Business Development and Portfolio
Carl Viel
President, CEO
Q-CROC - Recherche clinique en oncologie
Lucie D'Amours
CEO
Mikael Cyr
General Manager
Eric Azoulay
Vice-President Sales and Marketing
Shant Der Sarkissian
President, CEO
Doreen Miao
Director
Claude Leduc
President, CEO
Dmitri Boudovitch
President, CEO
Tanya Tolomeo
Head of Business Development
Shaun Gamboa
CTO
Catherine Forest-Nault
CEO
catherine.forestnault@lifeengine.ca
Adam Sefler
CEO, Co-Founder
Stéphane Gagné
Founder, President & CEO
Jean-Marc Juteau
Commissioner
SPM Therapeutics
Johane Guay
Directrice opérations
Jean-François Millau
CEO, Co-founder
Paul Lévesque
President, CEO
Jason Lam
Director, Market Access
Laurent Laferrière
CEO, Co-Founder
Louis Turcotte
CEO, Co-Founder
Frank Béraud
President, CEO
Pour plus d’information
Rachel Banville
Specialized Advisor, International Affairs
+1 418 731-1887
Rachel.Banville@invest-quebec.com
